Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Current Opinion in Obstetrics and Gynecology, 32, 1, S. 91-99
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2020
- Ereignis
-
Veröffentlichung
- (wer)
-
Ovid Technologies (Wolters Kluwer Health)
- (wann)
-
2020
- Urheber
- DOI
-
10.1097/gco.0000000000000593
- URN
-
urn:nbn:de:bvb:384-opus4-770950
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ditsch, Nina
- Rubio, Isabel T.
- Gasparri, Maria L.
- de Boniface, Jana
- Kuehn, Thorsten
- Universität Augsburg
- Ovid Technologies (Wolters Kluwer Health)
Entstanden
- 2020
Ähnliche Objekte (12)
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Immunotherapy: new options in breast cancer treatment
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Axillary breast: Navigating uncharted terrain
Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Immunotherapy: new options in breast cancer treatment
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Axillary breast: Navigating uncharted terrain
Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Immunotherapy: new options in breast cancer treatment
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Axillary breast: Navigating uncharted terrain